News
LLY
1209.00
-0.92%
-11.28
Eli Lilly's GLP-1 Pricing Problem Is Actually a Growth Opportunity
The Motley Fool · 6h ago
WST Q2 Beat and Raised 2026 Outlook Reinforce the HVP Growth Story
NASDAQ · 7h ago
Should Investors Buy WST as HVP Growth Meets a Premium Valuation?
NASDAQ · 7h ago
Is Novo Nordisk's Wegovy-Fueled Rebound Evaporating?
The Motley Fool · 7h ago
Pharma companies sour on Swiss drug applications amid Trump’s MFN policy
Seeking Alpha · 9h ago
Novo Nordisk CEO Doustdar says obesity drugs market won't be dominated by one player
Seeking Alpha · 9h ago
Novo Nordisk CEO Defends Lawsuit Against Eli Lilly (LLY)
TipRanks · 10h ago
Novo Nordisk Stock (NVO) Falls as CEO Weighs In on Obesity Drug Rivalry with Eli Lilly
TipRanks · 12h ago
The Morning Risk Report: Paramount Has Discussed -2-
The Wall Street Journal · 13h ago
The Morning Risk Report: Paramount Has Discussed Creating a Board to Ensure CNN's Independence
The Wall Street Journal · 13h ago
American Century Focused Global Growth Fund Q2 2026 Portfolio Review
Seeking Alpha · 16h ago
Vinod Khosla Says AI Is Creating a ‘Hyperabundance’ of New Drugs, but Testing Is Still ‘18th-Century’
Benzinga · 16h ago
Eli Lilly (LLY) Q2 2026 Earnings Call Transcript
The Motley Fool · 21h ago
Gamco Investors’ Mario Gabelli Ups Stake in Eli Lilly
TipRanks · 22h ago
Truist Financial Sticks to Their Buy Rating for Eli Lilly & Co (LLY)
TipRanks · 22h ago
Eli Lilly Sues Six Companies Over Unauthorized Retatrutide Sales
NASDAQ · 1d ago
Notable Wednesday Option Activity: OCUL, LLY, WEN
NASDAQ · 1d ago
I Underestimated Eli Lilly: Retatrutide Changes The Risk/Reward (Rating Upgrade)
Seeking Alpha · 1d ago
Eli Lilly Escalates Retatrutide Fight, Reports 200-Plus Illegal Sellers to Authorities
Benzinga · 1d ago
Analysts Are Bullish on These Healthcare Stocks: TScan Therapeutics (TCRX), Eli Lilly & Co (LLY)
TipRanks · 1d ago
More
Webull provides a variety of real-time LLY stock news. You can receive the latest news about Lilly Eli & Co through multiple platforms. This information may help you make smarter investment decisions.
About LLY
Eli Lilly and Company is a medicine company, which discovers, develops, manufactures, and market products in a single business segment called human pharmaceutical products. The Company manufacture and distribute its products through facilities in the United States, including Puerto Rico, and in Europe and Asia. The Company’s products are sold in approximately 90 countries. Its Cardiometabolic Health products Basaglar; Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, and others; Humulin, Humulin 70/30, and others; Jardiance; Mounjaro; Trulicity; Zepbound, and others. Its oncology products include Cyramza, Erbitux, Tyvyt, Verzenio, Retevmo, Jaypirca, and others. Its immunology products include Ebglyss, Olumiant, Omvoh, and Taltz. Its neuroscience products include Emgality and Kisunla. Its LillyDirect, a direct-to-patient digital health care platform, provides delivery of select Lilly medicines dispensed by third-party pharmacies to patients.